Influenza A (H5N1) monovalent vaccine, adjuvanted (Seqirus)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameInfluenza A (H5N1) monovalent vaccine, adjuvanted (Seqirus)
Drug Alias NameAudenz
ClassificationVaccines > Biological material > Viral vaccineVaccines > Application > Prophylactic vaccineVaccines > Vaccine type > Univalent vaccine +[4] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsInfluenza, Human
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2020/01/31
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesSeqirus Usa Inc
China Registration ClassN/A

Develop Information

Active CompaniesSeqirus
Inactive CompaniesN/A
Active IndicationsInfluenza, Human
Inactive IndicationsN/A

Other Information

ATC CodeJ07BB01
Related LinksWikipedia